196300 HLB펩

기본 정보

• 섹터: KOSDAQ:제조
• 시가총액: 436억원 (2026-06-30 기준)
• 첫 등장: — (마커 미등장)
• 태그: 매크로/바이오헬스 · 펩타이드 · 바이오 · 신약 · 항암 · 당뇨치료
• 네이버 금융: 🔗

기업개요

• 동사는 2000년 펩타이드 바이오소재 및 혁신 신약개발 전문기업으로 설립되었으며, 2016년 기술성장기업으로 코스닥에 상장함.
• 의약품, 원료의약품, 의약부외품 제조·판매 및 생명공학 관련 연구·기술개발을 하고 있으며, 의약용과 연구용 펩타이드 소재가 주요 매출을 차지함.
• GMP 생산시설을 보유하고 CDMO 서비스를 제공하며, 항균, 암 표적, 당뇨/비만치료 펩타이드 등 신약 파이프라인 구축과 상업화를 추진하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자	전일 종가	종가	등락률	시간외	vol	색깔	smart	외	연	금투	투	개	그외
2026-08-07	4,325	4,335	🔴 +0.23%	—	×0.4	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.1	+0.0
2026-08-06	4,300	4,325	🔴 +0.58%	—	×0.1	🔻 개인	-0.0억	-0.0	+0.0	+0.0	+0.0	+0.0	+0.0
2026-08-05	4,245	4,300	🔴 +1.30%	—	×0.2	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.1	+0.0
2026-08-04	4,160	4,245	🔴 +2.04%	—	×0.1	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0	+0.0
2026-08-03	3,980	4,160	🔴 +4.52%	—	×0.2	🟢 외인	+0.2억	+0.2	+0.0	+0.0	+0.0	-0.2	+0.0
2026-07-31	3,745	3,980	🔴 +6.28%	—	×0.1	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.1	+0.0
2026-07-30	3,855	3,745	🔵 -2.85%	—	×0.1	🟢 외인	+0.0억	+0.0	+0.0	+0.0	+0.0	-0.0	+0.0
2026-07-29	3,880	3,855	🔵 -0.64%	—	×0.2	🔻 개인	-0.0억	-0.0	+0.0	+0.0	+0.0	+0.1	-0.0
2026-07-28	3,980	3,880	🔵 -2.51%	—	×0.2	🟢 외인	+0.0억	+0.0	+0.0	+0.0	+0.0	-0.1	+0.0
2026-07-27	3,915	3,980	🔴 +1.66%	—	×0.5	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.1	+0.0
2026-07-24	3,885	3,915	🔴 +0.77%	—	×2.1	🔻 개인	-0.9억	-0.9	+0.0	+0.0	+0.0	+0.9	+0.0
2026-07-23	3,715	3,885	🔴 +4.58%	—	×0.2	🔻 개인	+0.0억	+0.0	+0.0	+0.0	+0.0	+0.0	+0.0
2026-07-22	3,770	3,715	🔵 -1.46%	—	×0.3	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.1	+0.0
2026-07-21	3,955	3,770	🔵 -4.68%	—	×0.4	🟢 외인	+0.0억	+0.0	+0.0	+0.0	+0.0	-0.0	+0.0
2026-07-20	4,135	3,955	🔵 -4.35%	—	×0.8	🟢 외인	+0.7억	+0.7	+0.0	+0.0	+0.0	-0.6	-0.1
2026-07-16	4,900	4,135	🔵 -15.61%	—	×6.9	🟢 외인	+0.3억	+0.3	+0.0	+0.0	+0.0	-0.4	+0.0
2026-07-15	3,770	4,900	🔴 +29.97%	—	×19.4	🔻 개인	-1.8억	-1.8	+0.0	+0.0	+0.0	+2.0	-0.2
2026-07-14	4,080	3,770	🔵 -7.60%	—	×0.8	🟢 외인	+0.0억	+0.0	+0.0	+0.0	+0.0	-0.0	+0.0
2026-07-13	4,010	4,080	🔴 +1.75%	—	×1.5	🟢 외인	+0.2억	+0.2	+0.0	+0.0	+0.0	-0.2	+0.0
2026-07-10	4,680	4,010	🔵 -14.32%	—	×5.4	🔻 개인	-0.4억	-0.4	+0.0	+0.0	+0.0	+0.4	+0.0
2026-07-09	4,575	4,680	🔴 +2.30%	—	×0.8	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.1	+0.0
2026-07-08	4,510	4,575	🔴 +1.44%	—	×0.5	🔻 개인	-0.2억	-0.2	+0.0	+0.0	+0.0	+0.2	+0.0
2026-07-07	4,580	4,510	🔵 -1.53%	—	×0.2	🔻 개인	-0.0억	-0.0	+0.0	+0.0	+0.0	+0.0	+0.0
2026-07-06	4,420	4,580	🔴 +3.62%	—	×0.9	🔻 개인	-0.0억	-0.0	+0.0	+0.0	+0.0	+0.0	+0.0
2026-07-03	4,415	4,420	🔴 +0.11%	—	×0.4	🟢 외인	+0.0억	+0.0	+0.0	-0.0	+0.0	-0.1	+0.0
2026-07-02	4,560	4,415	🔵 -3.18%	—	×1.4	🔻 개인	-0.1억	-0.1	+0.0	+0.0	+0.0	+0.0	+0.0
2026-07-01	4,650	4,560	🔵 -1.94%	—	×0.2	🔻 개인	-0.0억	-0.0	+0.0	+0.0	+0.0	+0.0	+0.0
2026-06-30	4,605	4,650	🔴 +0.98%	—	×0.7	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.2	+0.0
2026-06-29	4,340	4,605	🔴 +6.11%	—	×1.0	🟢 외인	+0.1억	+0.1	+0.0	+0.0	+0.0	-0.1	+0.0
2026-06-26	4,300	4,340	🔴 +0.93%	—	×0.7	🟢 외인	+0.0억	+0.0	+0.0	+0.0	+0.0	-0.0	+0.0
2026-06-25	4,595	4,300	🔵 -6.42%	—	×0.5	🔻 개인	-0.0억	-0.0	+0.0	+0.0	+0.0	+0.0	+0.0

일자별 사유 (최신 위)

2026-07-15

• 사유: —
• 섹터 컨텍스트: KOSDAQ:제조 (smart +1,144억)
• 매크로 원인: HLB 리보세라닙 FDA 제조 리스크 해소 기대에 그룹주 무더기 상한가, 미프진 허가 검토·항암신약 모멘텀 가세 (보통)